Vaxcyte PCVX

$ 90.16 2.0%

Quarterly report 2024-Q3
added 11-05-2024

Vaxcyte Financial Statements 2011-2024 | PCVX

Annual Financial Statements Vaxcyte

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	7.86 B	2.74 B	1.2 B	696 M	-	-	-	-	-	-	-	-	-
Shares	97.2 M	64.9 M	51.9 M	29.5 M	-	-	-	-	-	-	-	-	-
Historical Prices	80.9	42.2	23.2	23.6	-	-	-	-	-	-	-	-	-
Net Income	-402 M	-223 M	-100 M	-89.2 M	-50.3 M	-29.5 M	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-468 M	-232 M	-104 M	-89.6 M	-54.2 M	-35.5 M	-	-	-	-	-	-	-
Interest Expense	-	2 K	7 K	7 K	40 K	75 K	-	-	-	-	-	-	-
EBITDA	-465 M	-230 M	-102 M	-88.2 M	-52.7 M	-34.5 M	-	-	-	-	-	-	-
Operating Expenses	468 M	232 M	104 M	89.6 M	53.9 M	35.5 M	-	-	-	-	-	-	-
General and Administrative Expenses	60.7 M	39.8 M	25.3 M	16 M	8.55 M	5.39 M	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Vaxcyte

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	124 M	117 M	112 M	95.4 M	102 M	98.1 M	86.2 M	79.5 M	62 M	60.8 M	57.5 M	53 M	52.2 M	51.5 M	51.2 M	51 M	50.9 M	11.8 M	4.05 M	3.97 M	3.86 M	3.68 M	3.67 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-103 M	-129 M	-95 M	-	-92.7 M	-68.3 M	-60.5 M	-	-57.9 M	-48.5 M	-39 M	-	-26.6 M	-23.7 M	-21.2 M	-20.7 M	-21 M	-20.3 M	-27.1 M	-14.6 M	-11.3 M	-10.7 M	-13.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-140 M	-153 M	-114 M	-	-113 M	-87.1 M	-71.2 M	-	-58.6 M	-47.9 M	-39.2 M	-	-27 M	-23.7 M	-23.1 M	-19.5 M	-21.3 M	-21.2 M	-27.6 M	-15.8 M	-12.1 M	-12.2 M	-13.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	36.8 M	24.3 M	19.5 M	-	20.4 M	18.8 M	10.7 M	-	-	2 K	235 K	-	336 K	7 K	1.92 M	-1.28 M	7 K	7 K	7 K	1.22 M	9 K	11 K	273 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-138 M	-152 M	-113 M	-	-112 M	-86.3 M	-70.5 M	-	-57.9 M	-47.3 M	-38.6 M	-	-25.6 M	-22.9 M	-22.8 M	-19.5 M	-20.2 M	-20.5 M	-27.2 M	-15.8 M	-11.2 M	-11.6 M	-13.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	140 M	153 M	114 M	-	113 M	87.1 M	71.2 M	-	58.6 M	47.9 M	39.2 M	-	27 M	23.7 M	23.1 M	19.5 M	21.3 M	21.2 M	27.6 M	15.8 M	12.1 M	12.2 M	13.9 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	23 M	21.5 M	19.9 M	-	15.6 M	14.5 M	13.1 M	-	10.9 M	9.42 M	7.54 M	-	6.52 M	6.08 M	5.88 M	4.79 M	4.9 M	3.05 M	3.28 M	2.46 M	2.51 M	2.26 M	1.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency